Medicine and Health

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes

D. Sun, Z. Sang, et al.

This study explores the transformative potential of nanobodies in neutralizing SARS-CoV-2 variants, revealing their resistance to variants of concern and the discovery of unique neutralizing epitopes. Conducted by a talented team of researchers from the University of Pittsburgh and beyond, the findings highlight nanobodies' advantages over traditional antibodies, paving the way for innovative pan-coronavirus vaccines and therapeutics.